HuGE Literature Finder
|
||
Records 1-23
|
Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer.
PLoS genetics 2018 Apr 14 (4): e1007355. Paulo Paula, Maia Sofia, Pinto Carla, Pinto Pedro, Monteiro Augusta, Peixoto Ana, Teixeira Manuel |
|
Identification and analysis of CHEK2 germline mutations in Chinese BRCA1/2-negative breast cancer patients.
Breast cancer research and treatment 2018 Jan . Fan Zhenhua, Ouyang Tao, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Lin Benyao, Xu Ye, Xie Yunt |
|
Gene panel sequencing in familial Breast/Ovarian Cancer patients identifies multiple novel mutations also in genes others than BRCA1/2.
International journal of cancer 2016 Sep . Kraus Cornelia, Hoyer Juliane, Vasileiou Georgia, Wunderle Marius, Lux Michael P, Fasching Peter A, Krumbiegel Mandy, Uebe Steffen, Reuter Miriam, Beckmann Matthias W, Reis And |
|
Ready to clone: CNV detection and breakpoint fine-mapping in breast and ovarian cancer susceptibility genes by high-resolution array CGH.
Breast cancer research and treatment 2016 Aug . Hackmann Karl, Kuhlee Franziska, Betcheva-Krajcir Elitza, Kahlert Anne-Karin, Mackenroth Luisa, Klink Barbara, Di Donato Nataliya, Tzschach Andreas, Kast Karin, Wimberger Pauline, Schrock Evelin, Rump Andre |
|
A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer.
BMC medical genomics 2016 9 (1): 19. Mucaki Eliseos J, Caminsky Natasha G, Perri Ami M, Lu Ruipeng, Laederach Alain, Halvorsen Matthew, Knoll Joan H M, Rogan Peter |
|
Inherited predisposition to breast cancer among African American women.
Breast cancer research and treatment 2015 Jan 149 (1): 31-9. Churpek Jane E, Walsh Tom, Zheng Yonglan, Moton Zakiya, Thornton Anne M, Lee Ming K, Casadei Silvia, Watts Amanda, Neistadt Barbara, Churpek Matthew M, Huo Dezheng, Zvosec Cecilia, Liu Fang, Niu Qun, Marquez Rafael, Zhang Jing, Fackenthal James, King Mary-Claire, Olopade Olufunmilayo |
|
Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.
European journal of human genetics : EJHG 2014 Nov 22 (11): 1305-13. Castéra Laurent, Krieger Sophie, Rousselin Antoine, Legros Angélina, Baumann Jean-Jacques, Bruet Olivia, Brault Baptiste, Fouillet Robin, Goardon Nicolas, Letac Olivier, Baert-Desurmont Stéphanie, Tinat Julie, Bera Odile, Dugast Catherine, Berthet Pascaline, Polycarpe Florence, Layet Valérie, Hardouin Agnes, Frébourg Thierry, Vaur Dominiq |
|
Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer.
Proceedings of the National Academy of Sciences of the United States of America 2014 Oct 111 (42): 15172-7. Kiiski Johanna I, Pelttari Liisa M, Khan Sofia, Freysteinsdottir Edda S, Reynisdottir Inga, Hart Steven N, Shimelis Hermela, Vilske Sara, Kallioniemi Anne, Schleutker Johanna, Leminen Arto, Bützow Ralf, Blomqvist Carl, Barkardottir Rosa B, Couch Fergus J, Aittomäki Kristiina, Nevanlinna He |
|
Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Feb 20 (3): 764-75. Pennington Kathryn P, Walsh Tom, Harrell Maria I, Lee Ming K, Pennil Christopher C, Rendi Mara H, Thornton Anne, Norquist Barbara M, Casadei Silvia, Nord Alexander S, Agnew Kathy J, Pritchard Colin C, Scroggins Sheena, Garcia Rochelle L, King Mary-Claire, Swisher Elizabeth |
|
Identification of two poorly prognosed ovarian carcinoma subtypes associated with CHEK2 germ-line mutation and non-CHEK2 somatic mutation gene signatures.
Cell cycle (Georgetown, Tex.) 2014 13 (14): 2262-80. Ow Ghim Siong, Ivshina Anna V, Fuentes Gloria, Kuznetsov Vladimir |
|
Constitutional CHEK2 mutations are infrequent in early-onset and familial breast/ovarian cancer patients from Pakistan.
BMC cancer 2013 13 312. Rashid Muhammad U, Muhammad Noor, Faisal Saima, Amin Asim, Hamann U |
|
Identification of a novel in-frame deletion in BRCA2 and analysis of variants of BRCA1/2 in Italian patients affected with hereditary breast and ovarian cancer.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2012 Dec 50 (12): 2171-80. Vietri Maria Teresa, Molinari Anna Maria, Laura De Paola Maria, Cantile Flavia, Fasano Morena, Cioffi Miche |
|
Irrelevance of CHEK2 variants to diagnosis of breast/ovarian cancer predisposition in Polish cohort.
Journal of applied genetics 2011 May 52 (2): 185-91. Myszka Aleksander, Karpinski Pawel, Slezak Ryszard, Czemarmazowicz Halina, Stembalska Agnieszka, Gil Justyna, Laczmanska Izabela, Bednarczyk Damian, Szmida Elzbieta, Sasiadek Maria Malgorza |
|
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Breast cancer research : BCR 2011 13 (1): R20. Kuusisto Kirsi M, Bebel Aleksandra, Vihinen Mauno, Schleutker Johanna, Sallinen Satu-Lee |
|
BRCA1, BRCA2 and CHEK2 c.1100 delC mutations in patients with double primaries of the breasts and/or ovaries.
Journal of medical genetics 2010 Aug 47 (8): 561-6. Evans D Gareth, Ahmed Munaza, Bayliss Stuart, Howard Emma, Lalloo Fiona, Wallace Andr |
|
Single-nucleotide polymorphisms in the p53 pathway genes modify cancer risk in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.
Molecular carcinogenesis 2010 Jun 49 (6): 545-55. Yarden Ronit I, Friedman Eitan, Metsuyanim Sally, Olender Tzvia, Ben-Asher Edna, Papa Moshe |
|
Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 Dec 17 (12): 3567-72. Palmieri Rachel T, Wilson Melanie A, Iversen Edwin S, Clyde Merlise A, Calingaert Brian, Moorman Patricia G, Poole Charles, Anderson A Rebecca, Anderson Stephanie, Anton-Culver Hoda, Beesley Jonathan, Hogdall Estrid, Brewster Wendy, Carney Michael E, Chen Xiaoqing, Chenevix-Trench Georgia, Chang-Claude Jenny, Cunningham Julie M, Dicioccio Richard A, Doherty Jennifer A, Easton Douglas F, Edlund Christopher K, Gayther Simon A, Gentry-Maharaj Aleksandra, Goode Ellen L, Goodman Marc T, Kjaer Susanne Kruger, Hogdall Claus K, Hopkins Michael P, Jenison Eric L, Blaakaer Jan, Lurie Galina, McGuire Valerie, Menon Usha, Moysich Kirsten B, Ness Roberta B, Pearce Celeste Leigh, Pharoah Paul D P, Pike Malcolm C, Ramus Susan J, Rossing Mary Anne, Song Honglin, Terada Keith Y, Vandenberg David, Vierkant Robert A, Wang-Gohrke Shan, Webb Penelope M, Whittemore Alice S, Wu Anna H, Ziogas Argyrios, Berchuck Andrew, Schildkraut Joellen M, , , |
|
CHEK2 variants predispose to benign, borderline and low-grade invasive ovarian tumors.
Gynecologic oncology 2006 Sep 102 (3): 429-31. Szymanska-Pasternak J, Szymanska A, Medrek K, Imyanitov E N, Cybulski C, Gorski B, Magnowski P, Dziuba I, Gugala K, Debniak B, Gozdz S, Sokolenko A P, Krylova N Y, Lobeiko O S, Narod S A, Lubinski |
|
Analysis of CHEK2 gene for ovarian cancer susceptibility.
Gynecologic oncology 2004 Oct 95 (1): 62-9. Baysal Bora E, DeLoia Julie A, Willett-Brozick Joan E, Goodman Marc T, Brady Mark F, Modugno Francesmary, Lynch Henry T, Conley Yvette P, Watson Patrice, Gallion Holly |
|
Limited relevance of the CHEK2 gene in hereditary breast cancer.
International journal of cancer. Journal international du cancer 2004 Jun 110 (3): 320-5. Dufault MR, Betz B, Wappenschmidt B, Hofmann W, Bandick K, Golla A, Pietschmann A, Nestle-Krämling C, Rhiem K, Hüttner C, von Lindern C, Dall P, Kiechle M, Untch M, Jonat W, Meindl A, Scherneck S, Niederacher D, Schmutzler RK, Arnold N |
|
[Analysis of BRCA1/2 and CHEK2 mutations in ovarian cancer and primary multiple tumors involving the ovaries. Patients of Russian population using biochips].
Molekuliarnaia biologiia 0 41 (1): 37-42. Fedorova O E, Liubchenko L N, Paiadini Iu G, Kazubskaia T P, Amosenko F A, Gar'kavtseva R F, Zasedatelev A S, Nasedkina T |
|
BRCA1, BRCA2 and CHEK2 (1100 del C) germline mutations in hereditary breast and ovarian cancer families in South India.
Asian Pacific journal of cancer prevention : APJCP 0 4 (3): 203-8. Rajkumar Thangarajan, Soumittra Nagasamy, Nancy Nirmala Karunakaran, Swaminathan Rajaraman, Sridevi Veluswami, Shanta Vishwanath |
|
CHEK2 1100delC and Del5395bp mutations in BRCA-negative individuals from Serbian hereditary breast and ovarian cancer families.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 0 18 (3): 594-600. Krivokuca A, Dobricic J, Brankovic-Magic |
- Page last reviewed:Mar 1, 2018
- Page last updated:Jul 11, 2019
- Content source: